Kevin P. Regan

FDA investigator · also recorded as Age Kevin P. Regan

Appears on 7 documents from 2021 to 2024, most often at sites in Minnesota. Most often cites design and construction features (21 CFR 211.42).

7
Documents on file
4.7
Observations per 483
2021
First seen
2024
Most recent

What they cite most

From 33 observations

Activity by year

2021: 2, 2022: 1, 2023: 2, 2024: 2

Where

Minnesota 3 · Germany 1 · Illinois 1 · India 1 · Kentucky 1

Is Kevin P. Regan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Mylan Laboratories LimitedMay 17, 2024 · Hosur, India
483 IntegraDose Compounding Services LLCMar 1, 2024 · Minneapolis, Minnesota
483 ProMed Pharma, LLCOct 17, 2023 · Plymouth, Minnesota
483 Intervet International GMBHApr 28, 2023 · Unterscheissheim, Germany
483 L'OREAL USA, INC.Sep 30, 2022 · FLORENCE, Kentucky
483 IntegraDose Compounding Services LLCAug 2, 2021 · Minneapolis, Minnesota
483 Hydrox LaboratoriesJun 24, 2021 · Elgin, Illinois

About this profile

What does Kevin P. Regan inspect?

Kevin P. Regan appears on 7 documents on file covering 6 sites, most often in Minnesota.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kevin P. Regan is dated May 17, 2024.